Yuki Kogo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Evaluation of Oculomotor Function Following Sleep Improvement With Lemborexant in Older Adults With Insomnia.
Journal: Human psychopharmacology
Published: April 30, 2026
Effects of lemborexant on sleep quality and its association with morning alertness: Post hoc analysis of two phase 3 trials.
Journal: Sleep medicine: X
Published: December 22, 2025
Patients' Preferences for Parkinson's Disease Pharmacotherapy: An Online Discrete Choice Experiment.
Patients' Preferences for Parkinson's Disease Pharmacotherapy: An Online Discrete Choice Experiment.
Journal: Parkinson's disease
Published: May 12, 2025
Effect of lemborexant on sleep-wake state discrepancy in participants with insomnia disorder.
Journal: Psychopharmacology
Published: April 11, 2025
Safinamide as an adjunct to levodopa monotherapy in Asian patients with Parkinson's disease experiencing early wearing-off: a pooled analysis of the J-SILVER and KEEP studies.
Journal: Frontiers in neurology
Published: March 11, 2025
Gut Microbiome Composition Changes During Insomnia Treatment with Lemborexant.
Journal: Nature and science of sleep
Published: March 05, 2025
MR Imaging Indices for Brain Interstitial Fluid Dynamics and the Effects of Orexin Antagonists on Sleep.
Journal: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
Published: February 09, 2025
Assessing the Real-World, Long-Term Impact of Lemborexant on Sleep Quality in a Home-Based Clinical Study.
Journal: Nature and science of sleep
Published: November 08, 2023
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson's disease - network meta-analysis.
Journal: NPJ Parkinson's disease
Published: June 13, 2023
Analgesic effect of safinamide mesylate in a rat model of neuropathic pain.
Journal: Behavioural brain research
Published: March 01, 2023
The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study.
Journal: Frontiers in neurology
Published: August 03, 2021
Effects of safinamide adjunct therapy on pain in patients with Parkinson's disease: Post hoc analysis of a Japanese phase 2/3 study.
Journal: Journal of the neurological sciences
Published: April 08, 2021
Last Updated: 09/26/2026